The Global In vivo (CRO) Market is anticipated to achieve a Compound Annual Growth Rate (CAGR) of 8.2%, increasing from USD 3.61 Billion in 2020 to USD 6.44 Billion by 2028. The market growth is driven by several factors, including the pharmaceutical industry's preference for outsourcing clinical and preclinical trials to concentrate on core business activities, the growing trend of outsourcing research and development (R&D) activities, the rising number of patients and the prevalence of various diseases worldwide, which leads to an increased demand for CRO services. @ https://www.reportsanddata.com..../report-detail/in-vi
Like
Comment
Share
